ATC code D05 Antipsoriatics is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the WHO for the classification of drugs and other medical products. Subgroup D05 is part of the anatomical group D Dermatologicals.[1]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: QD05...[2] In ATCvet, this subgroup is named "QD05 Drugs for keratoseborrheic disorders".
D05A Antipsoriatics for topical use
-
- In ATCvet, this subgroup is named "QD05A Drugs for keratoseborrheic disorders, topical use".
D05AC Antracen derivatives
- D05AC01 Dithranol
- D05AC51 Dithranol, combinations
D05AD Psoralens for topical use
- D05AD01 Trioxysalen
- D05AD02 Methoxsalen
D05AX Other antipsoriatics for topical use
-
- In ATCvet, this subgroup is named "QD05AX Other drugs for keratoseborrheic disorders for topical use".
- D05AX01 Fumaric acid
- D05AX02 Calcipotriol
- D05AX03 Calcitriol
- D05AX04 Tacalcitol
- D05AX05 Tazarotene
- D05AX52 Calcipotriol, combinations
D05B Antipsoriatics for systemic use
-
- In ATCvet, this subgroup is named "QD05B Drugs for keratoseborrheic disorders, systemic use".
D05BA Psoralens for systemic use
- D05BA01 Trioxysalen
- D05BA02 Methoxsalen
- D05BA03 Bergapten
- D05BB01 Etretinate
- D05BB02 Acitretin
D05BX Other antipsoriatics for systemic use
-
- In ATCvet, this subgroup is named "QD05BX Other drugs for keratoseborrheic disorders for systemic use".
- D05BX51 Fumaric acid derivatives, combinations
References
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
